13 results
2021 ACR/VF Guidelines for Management of Polyarteritis Nodosa (PAN)

#PAN #Polyarteritis #Nodosa #ACR2021 #Management #rheumatology #algorithm #vasculitis
2021 ACR/VF Guidelines ... for Management ... ) #PAN #Polyarteritis ... Nodosa #ACR2021 #Management ... #rheumatology #
Guidelines for Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip
Guidelines for Perioperative ... Management of Antirheumatic ... MithuRheum #rheumatology ... #management #autoimmune ... #pharmacology #
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
Vasculitis Management ... - ACR/VF 2021 Guidelines ... for Treatment & Management ... Treatment #ACR2021 #Guidelines ... #algorithm #rheumatology
Polyarteritis Nodosa (PAN) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Severe Disease → Remission
) - Vasculitis Management ... - ACR/VF 2021 Guidelines ... Nodosa #Vasculitis #Management ... Treatment #ACR2021 #Guidelines ... #algorithm #rheumatology
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... #Management #Pulmonary ... LAMA #LABA #ICS #Guidelines
COPD Management Algorithm - GOLD 2019 guidelines 

Categorize into COPD GOLD A-D -> Initiate first-line therapy
COPD Management ... Algorithm - GOLD 2019 guidelines ... COPD GOLD 2019 guidelines ... #Management #Pulmonary ... #Algorithm #pharmacology
Vasopressors Table 
Rough properties by Target Receptor, Heart Rate/Inotropy, Systemic Vascular Resistance, Cardiac Output, Blood Pressure,
Blood Pressure, Pulmonary ... Vascular Resistance, Main ... Properties #Table #Pharmacology ... #Effect #Management
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
effusions, weight gain ... Imaging: CXR- pulmonary ... APML #diagnosis #management ... #hematology #oncology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Disease: • 10%-15% Pulmonary ... , INC risk PE, Pulmonary ... lubricants • Pharmacologic ... Sjogrens #Syndrome #Rheumatology ... #Diagnosis #Management
Diagnosis and Management of Achalasia - ACG Guidelines

Who to suspect?
 • Patients presenting with progressive dysphagia
Diagnosis and Management ... Achalasia - ACG Guidelines ... heart burn, chest pain ... Botulinum toxin • Pharmacologic ... #ACG #Guidelines